MRNA trailing returns
How Moderna Inc. (MRNA) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through July 24, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-07-24. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -5.2% | |
| 1 week | — | -12.6% | |
| 1 month | — | -10.5% | |
| YTD | — | +83.3% | |
| 1 year | +55.9% | +55.9% | |
| 5 years | -31.1% | -84.5% | |
| Since inception (2018) | +15.0% | +190.6% |
Growth of MRNA#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-07-24). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from MRNA's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ
- What is Moderna Inc.'s return since inception?
- Since 2018, Moderna Inc. (MRNA) has compounded at about +15.0% a year — +190.6% in total.